HeadlineShine

Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

Hindustan TimesWhy India rejected a patent application for shorter drug-resistant TB treatment | Explained
Image: The Hindu

The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care

Summary from The Hindu

Read the full story on The Hindu
React

Trending now

More top stories

See all →

Top stories in India

See all →